Imara raises $31M, licenses sickle cell therapies

Sickle cell play Imara Inc. (Cambridge, Mass.) raised a tranched $31 million series A round led by New Enterprise Associates (NEA).

Read the full 219 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE